What Is Cingulate Inc. (CING) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Cingulate Inc.'s intrinsic value is estimated at $4.42, presenting a divided outlook at the current price of $4.59. With an average implied return of -3.6% across a split 3–4 (bull–bear) consensus, the model spread of +118.9% underscores analytical uncertainty. Notably, First Chicago sees the most upside at +66.5% (fair value: $7.64), while EPV is the most conservative at -52.4% ($2.19). The spread between these extremes — +118.9% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About CING?
8 of 13 models are currently active for CING. Of these, 4 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates CING's intrinsic value at $2.30, implying -49.9% downside from the current price. See which stocks rank higher →
How Does CING Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, CING ranks #383 by Quality of Company score. CirclFi's QOC score of 3.2/10 evaluates 32 fundamental signals. A score of 3.2 signals below-average fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a healthcare company, Cingulate Inc. operates in a sector where revenue per drug is a critical driver of valuation. Investors evaluating CING should weigh these sector-specific dynamics alongside our model-derived fair values.
Is CING a Value Trap?
CirclFi's Value Trap algorithm assigns CING a score of 39/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
8 of 13 models are active for Cingulate Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Cingulate Inc.'s fundamental quality profile registers 3.2/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +118.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CING valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CING's 8 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad